Clinical Trial Update: Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of starting a dolutegravir-based regimen on the HIV-1 proviral DNA reservoir in treatment-naive and experienced patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: HIV-1 Infection | Phase 4 | Status: UNKNOWN